Literature DB >> 6797401

The complete amino acid sequence of a prototype immunoglobulin-lambda light-chain-type amyloid-fibril protein AR.

K Sletten, J B Natvig, G Husby, J Juul.   

Abstract

The amino acid sequence of an amyloid-fibril protein of immunoglobulin light-chain type (AL) was elucidated. The sequence determination involved digesting the protein with trypsin, thermolysin and pepsin. The protein was found to consist of 154 amino acid residues and is thus missing about half of the constant region of a light chain. A certain heterogeneity in the length of the polypeptide was observed in the C-terminal region. The amino acid sequence from CDR (complementary-determining region) 1 and FR (framework region) 3 indicated an oligoclonal origin of the protein. By comparing the primary structure of protein AR with other lambda- and even kappa-chains, it was revealed that protein AR had an insertion of two residues of aspartic acid, namely residues 68 and 69, which has not been reported previously in light chains. The overall sequence homology in the variable region showed that protein AR is more similar to V lambda V than to the other subgroups [Kabat, Wu & Bilofsky (1979) Variable regions of Immunoglobulin Chains, Medical Computer Systems, Bolt, Beranek and Newman, Cambridge, MA].

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6797401      PMCID: PMC1162927          DOI: 10.1042/bj1950561

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  17 in total

1.  The preparation and enzymatic hydrolysis of reduced and S-carboxymethylated proteins.

Authors:  A M CRESTFIELD; S MOORE; W H STEIN
Journal:  J Biol Chem       Date:  1963-02       Impact factor: 5.157

Review 2.  Amyloidosis: its nature and pathogenesis.

Authors:  G G Glenner; W D Terry; C Isersky
Journal:  Semin Hematol       Date:  1973-01       Impact factor: 3.851

3.  The complete amino-acid sequence of non-immunoglobulin amyloid fibril protein AS in rheumatoid arthritis.

Authors:  K Sletten; G Husby
Journal:  Eur J Biochem       Date:  1974-01-03

4.  High recovery of tryptophan from acid hydrolysates of proteins.

Authors:  H Matsubara; R M Sasaki
Journal:  Biochem Biophys Res Commun       Date:  1969-04-29       Impact factor: 3.575

5.  Hydrolysis of phenylthiohydantoins of amino acids.

Authors:  H O Van Orden; F H Carpenter
Journal:  Biochem Biophys Res Commun       Date:  1964       Impact factor: 3.575

6.  [Pattern of antibody structure. The amino acid sequence of a monoclonal immunoglobulin L-chain of lambde-type, subgroup I (Bence-Jones-protein Vor.). A contribution to the elucidation of the origin of antibody specificity (author's transl)].

Authors:  M Engelhard; N Hilschmann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1975-09

7.  Amyloid fibril protein related to immunoglobulin lambda-chains.

Authors:  M Skinner; M D Benson; A S Cohen
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

8.  N-terminal amino acid sequence of amyloid fibril protein AR, prototype of a new lambda-variable subgroup, V lambda V.

Authors:  K Sletten; G Husby; J B Natvig
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

9.  Amino acid sequence of the N-terminal 139 residues of light chain derived from a homogeneous rabbit antibody.

Authors:  J C Jaton
Journal:  Biochem J       Date:  1974-07       Impact factor: 3.857

10.  New, third class of amyloid fibril protein.

Authors:  G Husby; J B Natvig; K Sletten
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

View more
  14 in total

1.  Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.

Authors:  M Cogné; J L Preud'homme; M Bauwens; G Touchard; P Aucouturier
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

2.  Structural studies of a carbohydrate-containing immunoglobulin-lambda-light-chain amyloid-fibril protein (AL) of variable subgroup III.

Authors:  E Holm; K Sletten; G Husby
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

3.  The amino acid sequence of a carbohydrate-containing immunoglobulin-light-chain-type amyloid-fibril protein.

Authors:  T Tveteraas; K Sletten; P Westermark
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

4.  The primary structure of the variable region of an immunoglobin IV light-chain amyloid-fibril protein (AL GIL).

Authors:  E M Fykse; K Sletten; G Husby; G G Cornwell
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

5.  A serum AA-like protein as a common constituent of secondary amyloid fibrils.

Authors:  P Westermark; K Sletten
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

6.  Prealbumin variants in the amyloid fibrils of Swedish familial amyloidotic polyneuropathy.

Authors:  P Westermark; K Sletten; B O Olofsson
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

7.  Senile cerebral amyloid. Prealbumin as a common constituent in the neuritic plaque, in the neurofibrillary tangle, and in the microangiopathic lesion.

Authors:  T Shirahama; M Skinner; P Westermark; A Rubinow; A S Cohen; A Brun; T L Kemper
Journal:  Am J Pathol       Date:  1982-04       Impact factor: 4.307

8.  Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA).

Authors:  G Marhaug; K Sletten; G Husby
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

9.  Malate dehydrogenase from the thermophilic green bacterium Chloroflexus aurantiacus: purification, molecular weight, amino acid composition, and partial amino acid sequence.

Authors:  A K Rolstad; E Howland; R Sirevåg
Journal:  J Bacteriol       Date:  1988-07       Impact factor: 3.490

10.  Complementary DNA sequence of human amyloidogenic immunoglobulin light-chain precursors.

Authors:  P Aucouturier; A A Khamlichi; J L Preud'homme; M Bauwens; G Touchard; M Cogné
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.